HUMAN MILK OLIGOSACCHARIDES MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America continues to dominate the global human milk oligosaccharides market, primarily led by the U.S. The region is expected to account for 37.6% of the market share in 2024. The region has a strong foothold of major players that are continuously investing in clinical research and product development activities. Numerous clinical studies validating the health benefits of HMOs have created widespread awareness among consumers in the region. This has boosted the incorporation of HMOs into infant formula, pediatric nutrition, and other pediatric healthcare products. Moreover, the growth of the nutritional and dietary supplement industry has widened the application scope of HMOs.

Asia Pacific is identified as the fastest growing regional market. China represents a highly lucrative market driven by improving living standards, rising health consciousness, and expanding consumer base. There is a growing interest among Chinese manufacturers to develop advanced pediatric nutrition products. This has prompted them to form partnerships with global leaders for technology transfers. Additionally, several rural and underdeveloped parts of the country still face problems of malnutrition and infant mortality. This has fostered government support through rural healthcare projects involving HMOs. Japan too is a major domestic market characterized by an aging population and increasing preference for preventive healthcare solutions.